Maria A. Papathanasopoulos
University of the Witwatersrand
South Africa
About
No AI summary yet.
Metrics
- Publications
- 64
- Citations
- 1.4K
- h-index
- 24
- Publishing journals
- 41
- Years of publications
- 20+
- Active since
- 2007
- References
- 2.3K
- Institutions
- 2
Publication history
Latest publications
- Causes of death in adults living with HIV in South Africa: A single-centre postmortem study.
- Consensus study on factors influencing the academic entrepreneur in a middle-income country’s university enterprise
- Ibogaine administration following repeated morphine administration upregulates myelination markers 2′, 3′-cyclic nucleotide 3′-phosphodiesterase (CNP) and myelin basic protein (MBP) mRNA and protein expression in the internal capsule of Sprague Dawley rats
- Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis
- K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine
- Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir
- Shifting the center of gravity for addressing the rising cancer disease burden in Africa: A rationale for African-based integrative infectious diseases and oncology research
- HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6
- Immunization with HIV-1 trimeric SOSIP.664 BG505 or founder virus C (FVCEnv) covalently complexed to two-domain CD4S60C elicits cross-clade neutralizing antibodies in New Zealand white rabbits
- Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics
- POPIA Code of Conduct for Research (with corrigendum)
- Corrigendum: POPIA Code of Conduct for Research
- Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection
- HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
- Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1
- HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
- Screening of the NIH clinical collection for inhibitors of HIV-1 integrase activity
- An update on the biophysical character of the human eukaryotic elongation factor 1 beta: Perspectives from interaction with elongation factor 1 gamma
- HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: Results from a national survey in South Africa
- Molecular characterisation of rifampicin-resistant <i>Mycobacterium tuberculosis</i> strains from Malawi
No publications in the index yet.